Skip to main navigation Skip to search Skip to main content

Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation

  • J. Jarman
  • , V. Glover
  • , M. Sandler
  • , N. Turjanski
  • , G. Stern

Research output: Contribution to journalArticlepeer-review

Abstract

An increase in platelet monoamine oxidase (MAO) B activity in drug-free parkinsonians (n = 6) compared with healthy controls (n = 10) has been confirmed using both phenylethylamine (PEA) and dopamine as substrates, reaching statistical significance in the case of PEA oxidising activity (p < 0.05). Thus, certain reports of raised platelet MAO B activity towards PEA but decreased activity towards dopamine in parkinsonians, raising the possibility of the existence of an abnormal form of MAO B in this condition, cannot be supported.
Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalJournal of Neural Transmission - Parkinson's Disease and Dementia Section
Volume5
DOIs
Publication statusPublished - Feb 1993

Keywords

  • parkinsons disease
  • monoamine oxidase
  • platelet
  • Biological sciences

Fingerprint

Dive into the research topics of 'Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation'. Together they form a unique fingerprint.

Cite this